IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Peregrine Pharma Inc New

CUSIP: 713661106 | 1 institutional holders

Quarters

Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2013

Reynolds Capital Management LLC13,100
0.0% of portfolio›$17
StyleTurnoverLocationFiled
Reynolds Capital Management LLC
13,100$170.0%N/AN/ALas Vegas, NV2013-08-06